Templeton NS - Search Results

1

Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vector.

Ramesh R, Saeki T, Templeton NS, Ji L, Stephens LC, Ito I, Wilson DR, Wu Z, Branch CD, Minna JD, Roth JA. Ramesh R, et al. Among authors: templeton ns. Mol Ther. 2001 Mar;3(3):337-50. doi: 10.1006/mthe.2001.0266. Mol Ther. 2001. PMID: 11273776 Free article.

2

Phase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humans.

Lu C, Stewart DJ, Lee JJ, Ji L, Ramesh R, Jayachandran G, Nunez MI, Wistuba II, Erasmus JJ, Hicks ME, Grimm EA, Reuben JM, Baladandayuthapani V, Templeton NS, McMannis JD, Roth JA. Lu C, et al. Among authors: templeton ns. PLoS One. 2012;7(4):e34833. doi: 10.1371/journal.pone.0034833. Epub 2012 Apr 25. PLoS One. 2012. PMID: 22558101 Free PMC article. Clinical Trial.

3

Inhibition of breast tumor progression by systemic delivery of the maspin gene in a syngeneic tumor model.

Shi HY, Liang R, Templeton NS, Zhang M. Shi HY, et al. Among authors: templeton ns. Mol Ther. 2002 Jun;5(6):755-61. doi: 10.1006/mthe.2002.0602. Mol Ther. 2002. PMID: 12027560 Free article.

4

Noninvasive imaging of cationic lipid-mediated delivery of optical and PET reporter genes in living mice.

Iyer M, Berenji M, Templeton NS, Gambhir SS. Iyer M, et al. Among authors: templeton ns. Mol Ther. 2002 Oct;6(4):555-62. doi: 10.1006/mthe.2002.0700. Mol Ther. 2002. PMID: 12385291 Free article.

5

Liposomal enhancement of the antitumor activity of conditionally replication-competent adenoviral plasmids.

Yotnda P, Davis AR, Hicks MJ, Templeton NS, Brenner MK. Yotnda P, et al. Among authors: templeton ns. Mol Ther. 2004 Apr;9(4):489-95. doi: 10.1016/j.ymthe.2004.01.018. Mol Ther. 2004. PMID: 15093179 Free article.

6

Optimization of gene expression in nonactivated circulating lymphocytes.

Zhang Y, Lu H, LiWang P, Sili U, Templeton NS. Zhang Y, et al. Among authors: templeton ns. Mol Ther. 2003 Oct;8(4):629-36. doi: 10.1016/s1525-0016(03)00231-4. Mol Ther. 2003. PMID: 14529836 Free article.

7

A combinatorial approach for targeted delivery using small molecules and reversible masking to bypass nonspecific uptake in vivo.

Shi Q, Nguyen AT, Angell Y, Deng D, Na CR, Burgess K, Roberts DD, Brunicardi FC, Templeton NS. Shi Q, et al. Among authors: templeton ns. Gene Ther. 2010 Sep;17(9):1085-97. doi: 10.1038/gt.2010.55. Epub 2010 May 13. Gene Ther. 2010. PMID: 20463761 Free PMC article.

8

Bilamellar cationic liposomes protect adenovectors from preexisting humoral immune responses.

Yotnda P, Chen DH, Chiu W, Piedra PA, Davis A, Templeton NS, Brenner MK. Yotnda P, et al. Among authors: templeton ns. Mol Ther. 2002 Mar;5(3):233-41. doi: 10.1006/mthe.2002.0545. Mol Ther. 2002. PMID: 11863412 Free article.

9

Enhanced gene expression in breast cancer cells in vitro and tumors in vivo.

Lu H, Zhang Y, Roberts DD, Osborne CK, Templeton NS. Lu H, et al. Among authors: templeton ns. Mol Ther. 2002 Dec;6(6):783-92. doi: 10.1006/mthe.2002.0813. Mol Ther. 2002. PMID: 12498774 Free article.

10

Identification and removal of colanic acid from plasmid DNA preparations: implications for gene therapy.

Firozi P, Zhang W, Chen L, Quiocho FA, Worley KC, Templeton NS. Firozi P, et al. Among authors: templeton ns. Gene Ther. 2010 Dec;17(12):1484-99. doi: 10.1038/gt.2010.97. Epub 2010 Jul 22. Gene Ther. 2010. PMID: 20664542 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters